Posted On: 01/16/2015 9:46:12 AM
Post# of 30067
Re: Loco motion #15377
LymPro's 94% sensitivity is more accurate in distinguishing those with AD from other cognitive disorders than the screening test they're using now. And it is one third the cost, and less invasive to patients.
The great thing about the Georgetown tests is not that they are so much more accurate than Lympro, but that they are different "modalities" or methods of diagnosing AD. By gaining Georgetowns 2 tests in addition to Lympro it gives us 3 different modalities in diagnosing AD. Together they will be nearly 100% accurate. We won't have all 3 ready within a year, so do you expect pharmas to put on hold all their alzheimer's testing in 2015?
Sometimes Loco, I wonder about the questions you ask? A lot of them could easily be answered by yourself if you were paying attention to what's going on.
The great thing about the Georgetown tests is not that they are so much more accurate than Lympro, but that they are different "modalities" or methods of diagnosing AD. By gaining Georgetowns 2 tests in addition to Lympro it gives us 3 different modalities in diagnosing AD. Together they will be nearly 100% accurate. We won't have all 3 ready within a year, so do you expect pharmas to put on hold all their alzheimer's testing in 2015?
Sometimes Loco, I wonder about the questions you ask? A lot of them could easily be answered by yourself if you were paying attention to what's going on.
(0)
(0)
